Livforsakringsbolaget Skandia Omsesidigt boosted its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 2,324.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 53,090 shares of the industrial products company's stock after buying an additional 50,900 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt's holdings in Xylem were worth $6,868,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in XYL. Price T Rowe Associates Inc. MD grew its position in shares of Xylem by 689.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,708,963 shares of the industrial products company's stock valued at $443,074,000 after purchasing an additional 3,239,203 shares during the last quarter. Nuveen LLC acquired a new stake in Xylem during the first quarter worth approximately $99,726,000. OVERSEA CHINESE BANKING Corp Ltd boosted its position in Xylem by 390.5% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock worth $122,009,000 after acquiring an additional 813,100 shares during the last quarter. Vaughan Nelson Investment Management L.P. acquired a new stake in Xylem during the first quarter worth approximately $89,828,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Xylem during the fourth quarter worth approximately $83,139,000. 87.96% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm's stock in a transaction on Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the transaction, the chief accounting officer directly owned 2,957 shares of the company's stock, valued at $413,861.72. This trade represents a 25.27% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.27% of the stock is currently owned by corporate insiders.
Xylem Price Performance
Shares of XYL stock opened at $141.98 on Tuesday. The firm has a market cap of $34.56 billion, a P/E ratio of 36.88, a P/E/G ratio of 2.45 and a beta of 1.09. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43. Xylem Inc. has a 1-year low of $100.47 and a 1-year high of $145.33. The firm has a fifty day moving average of $138.41 and a two-hundred day moving average of $127.67.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.15 by $0.11. The company had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm's revenue for the quarter was up 6.1% compared to the same quarter last year. During the same period last year, the business earned $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, research analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.
Xylem Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.1%. The ex-dividend date of this dividend is Thursday, August 28th. Xylem's dividend payout ratio (DPR) is currently 41.56%.
Analysts Set New Price Targets
A number of brokerages recently issued reports on XYL. JPMorgan Chase & Co. began coverage on shares of Xylem in a research report on Friday, May 30th. They set an "overweight" rating and a $148.00 target price on the stock. TD Cowen raised their target price on shares of Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a research report on Tuesday, August 26th. Cowen reaffirmed a "hold" rating on shares of Xylem in a research note on Tuesday, August 26th. UBS Group increased their price target on shares of Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a research note on Tuesday, August 5th. Finally, Mizuho increased their price target on shares of Xylem from $125.00 to $140.00 and gave the stock a "neutral" rating in a research note on Friday. Six research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $150.75.
Get Our Latest Stock Analysis on Xylem
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.